Assembly Biosciences, Inc. License and Services Revenue (Deprecated 2018-01-31)
Assembly Biosciences, Inc. (ASMB) reported License and Services Revenue (Deprecated 2018-01-31) of $3.57 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-07.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2018-05-07
- Assembly Biosciences, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $3.57M, a 420.93% increase year-over-year.
- Assembly Biosciences, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $3.32M.
- Assembly Biosciences, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.66M.
- Assembly Biosciences, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $2.36M.
- Assembly Biosciences, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2017 was $9.02M.
- Assembly Biosciences, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2016 was $0.00.
- Assembly Biosciences, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2015 was $0.00.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month | License and Services Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $3.57M 10-Q · filed 2018-05-07 | $6.88M derived: sum of 2 quarters · filed 2018-05-07 | $9.54M derived: sum of 3 quarters · filed 2018-05-07 | $11.90M derived: sum of 4 quarters · filed 2018-05-07 |
| 2017-12-31 | $3.32M 10-K · filed 2018-03-08 | $5.98M derived: sum of 2 quarters · filed 2018-03-08 | $8.33M derived: sum of 3 quarters · filed 2018-03-08 | $9.02M 10-K · filed 2018-03-08 |
| 2017-09-30 | $2.66M 10-K · filed 2018-03-08 | $5.02M derived: sum of 2 quarters · filed 2018-03-08 | $5.70M 10-Q · filed 2017-11-01 | $5.70M derived: sum of 4 quarters · filed 2018-05-07 |
| 2017-06-30 | $2.36M 10-K · filed 2018-03-08 | $3.04M 10-Q · filed 2017-08-09 | $3.04M derived: sum of 3 quarters · filed 2018-05-07 | $3.04M derived: sum of 4 quarters · filed 2018-05-07 |
| 2017-03-31 | $684.37K 10-Q · filed 2018-05-07 | $684.37K derived: sum of 2 quarters · filed 2018-05-07 | $684.37K derived: sum of 3 quarters · filed 2018-05-07 | $684.37K derived: sum of 4 quarters · filed 2018-05-07 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 derived: sum of 3 quarters · filed 2018-03-08 | $0.00 10-K · filed 2018-03-08 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | $0.00 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |